Asia-Pacific L-carnosine market is estimated to grow at a CAGR of around 5.3% during the forecast period. Increasing prevalence of chronic diseases is one of the key motivating factors for the growth of the market. For instance, the adult diabetic population in India was 69,188 cases per 100,000 people in 2018 with the prevalence rate reaching 9.3% as per World Health Organization (WHO). In 2018, over 1 million mortalities occurred due to diabetes in India. This, in turn, is expected to drive the demand for L-carnosine as a dietary supplement to improve glycaemic control in diabetes and support cardiovascular health.

Asia-Pacific L-carnosine market is segmented on the basis of application and geography. Based on the application, the market is segmented into autism, diabetes support, skin support, CVD support, joint support, and others. Others segment include digestion support, Parkinson’s disease, and Alzheimer’s disease. In 2019, the skin support segment is projected to contribute a significant share to the global market. 

Moreover, the report covers the country-level analysis of the Asia-Pacific L-carnosine market. The economies covered in the report studied include China, Japan, India, and Rest of Asia-Pacific. China is one of the largest economies across the globe and is known for its significant economic growth, healthcare system, infrastructure, and technological advancement. The geriatric population, healthcare reforms, and favorable regulations are estimated to back the growth of the market in the country. The market in China is backed by increasing diabetes and kidney-related cases along with the trend towards L-carnosine as a dietary supplement to support health and cardiovascular health.

Companies operating in the market include Hamari Chemicals, Ltd., Panvo Organics Pvt Ltd., Foodchem International Corp., Manus Akttevs Biopharma LLP, and Zeria Pharmaceutical Co., Ltd. Manus Akttevs Biopharma LLP offers products through three categories that include APIs, intermediates, and other products. Under the API category, L-carnosine offered by the company is supplied across the globe. The L-carnosine products are intended for the requirements of R&D quantities and commercials, based on the status of the product. The company also provides intermediates of L-Carnosine. Additionally, Foodchem International Corp. offers L-Carnosine in its food ingredient segment. The company is manufacturing and supplying L-Carnosine for more than 10 years. The company sells at least 5 kg of L-Carnosine directly.

Research Methodology

The market study of the Asia-Pacific L-carnosine market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Authentic public databases 
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report is intended for the pharmaceutical companies, healthcare industry, research institutes, academic institutes, dietary supplement companies, investing companies, government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models. 

Market Segmentation:

• Asia-Pacific L-carnosine Market Research and Analysis by Application

The Report covers:

• Comprehensive research methodology of the Asia-Pacific L-carnosine market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Asia-Pacific L-carnosine market.
• Insights about market determinants which are stimulating the Asia-Pacific L-carnosine market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.